Skip to Main content Skip to Navigation
Journal articles

The Cost of Trust: The World Health Organization and Vaccination's Contested Economization in France

Abstract : This article explores the role of the World Health Organization (WHO) within the tumultuous history of the hepatitis B vaccine in France, including a controversy that erupted in 1996 and lasted several years. When the first hepatitis B vaccine was commercialized in France in 1981, it inaugurated a new era in the industry characterized by high prices, an unprecedented number of patents and aggressive commercial competition. By inscribing the hepatitis B vaccine controversy into a broader, global history of the economization of immunization – in which the WHO played a central role – this article reframes the causes and implications of a controversy that both actors and scholars have approached through a primarily national lens. The challenge posed to the economic approach to immunization prepared the ground for subsequent critiques of vaccines as commodities. The article discusses a key transformation in the recent transatlantic history of public health by focusing on the perceived association of immunization with a contested economic order.
Complete list of metadata

https://hal-sciencespo.archives-ouvertes.fr/hal-03700735
Contributor : Gaëtan Thomas Connect in order to contact the contributor
Submitted on : Tuesday, June 21, 2022 - 1:55:00 PM
Last modification on : Wednesday, June 22, 2022 - 3:44:54 AM

Identifiers

Collections

Citation

Gaëtan Thomas. The Cost of Trust: The World Health Organization and Vaccination's Contested Economization in France. Journal of Contemporary History, SAGE Publications, 2021, pp.002200942110578. ⟨10.1177/00220094211057833⟩. ⟨hal-03700735⟩

Share

Metrics

Record views

7